Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA)

Vaccine

Volumn 24, Issue 19, 2006, Pages 4152-4160

  Abdalrhman, Ihab ^a   Gurt, Irina ^a   Katz, Ehud ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Lister Elstree; MVA; Vaccinia

Indexed keywords

LIVE VACCINE; MODIFIED VACCINIA VIRUS ANKARA VACCINE; UNCLASSIFIED DRUG; VACCINIA VACCINE; VACCINIA VIRUS LISTER VACCINE; VACCINIA VIRUS WESTERN RESERVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG TISSUE LEVEL; EMBRYO; FEMALE; IMMUNIZATION; INOCULATION; LETHALITY; LOW DRUG DOSE; LUNG; MODIFIED VACCINIA VIRUS ANKARA; MOUSE; NONHUMAN; ORTHOPOXVIRUS; PRIORITY JOURNAL; REVACCINATION; SMALLPOX; TISSUE CULTURE; VACCINIA VIRUS; VACCINIA VIRUS LISTER; VACCINIA VIRUS WESTERN RESERVE; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS STRAIN; WEIGHT REDUCTION;

ANIMALS; BRAIN; FEMALE; HUMANS; ISRAEL; MICE; MICE, INBRED BALB C; ORTHOPOXVIRUS; POXVIRIDAE INFECTIONS; SMALLPOX; SMALLPOX VACCINE; VACCINES, ATTENUATED; VACCINIA VIRUS; VIRULENCE; VIRUS CULTIVATION;

EID: 33646155311     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.02.012     Document Type: Article

References (24)

1. Lublin-Tennenbaum T., Katzenelson E., El-Ad B., and Katz E. Correlation between cutaneous reaction in vaccinees immunized against smallpox and antibody titer determined by plaque neutralization test and ELISA. Viral Immunol 3 (1990) 19-25
2. El-Ad B., Roth Y., Winder A., Tocher Z., Lublin-Tennenbaum T., Katz E., et al. The persistence of neutralizing antibodies after vaccination against smallpox. J Infect Dis 161 (1990) 446-448
3. Stienlauf S., Shoresh M., Solomon A., Lublin-Tennenbaum T., Atsmon Y., Meirovich Y., et al. Kinetics of formation of neutralizing antibodies against vaccinia virus following revaccination. Vaccine 17 (1999) 201-204
4. Mayr A., Hochstein-Mintzel V., and Stickl H. Abstammung, eigenschaften und verwendung des attenuierten vaccinia-stammes MVA. Infection 3 (1975) 6-14
5. Mayr A., Stickl H., Muller H.K., Danner K., and Singer H. Der pockenimpfstamm MVA: Marker, genetische struktur, erfahrungen mit der parenteralen schutzimpfung und verhalten im abwehrgeschwachten organismus. Zbl Bakt Hyg 167 (1978) 375-390
6. Carroll M.W., and Moss B. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Virology 238 (1997) 198-211
7. Wyatt L.S., Carroll M.W., Czerny C.P., Merchlinsky M., Sisler J.R., and Moss B. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara. Virology 251 (1998) 334-342
8. Hochstein-Mintzel V., Huber H.C., and Stickl H. Virulenz und immunogentat eines midifizierten vaccinia-virus (Stamm MVA). Z Immun Forsch 144 (1972) 140-145
9. Stittelaar K.J., Kuiken T., de Swart R.L., van Amerongen G., Vos H.W., et al. Safety of modified vaccinia Ankara (MVA) in immune suppressed macaques. Vaccine 19 (2001) 3700-3709
10. Belyakov I.M., Earl P., Dzutsev A., Kuznetsov V.A., Lemon M., Wyatt L.S., et al. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci USA 100 (2003) 9458-9463
11. Drexler I., Staib C., Kastenmuller W., Stevanovic S., Schmidt B., Lemonnier F.A., et al. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proc Natl Acad Sci USA 100 (2003) 217-222
12. Wyatt L.S., Earl P.L., Eller L.A., and Moss B. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci USA 101 (2004) 4590-4595
13. Mahnel H., and Mayr A. Erfahrungen bei der schutzimpfung gegen orthopocken von mensch und tier mit dem impfstamm MVA. Berl Munch Tierarzt Wschr 107 (1994) 253-256
14. Stickl H., Hochstein-Mintzel V., Mayr A., Huber H.C., Schafer H., and Holzner A. MVA-stufenimpfung gegen pocken. Kleinische erprobung des attenuierten pocken-lebendimpfstoffes, stamm MVA. Dtsch Med Wschr 99 (1974) 2386-2392
15. Henderson DA, Moss B. Smallpox and vaccinia. In: Plotkin SA, Orenstein WA (Eds.), Vaccines. Philadelphia, PA: WB Saunders; 1999. p. 74-97.
16. Turner G.S. Respiratory infection of mice with vaccinia virus. J Gen Virol 1 (1967) 399-402
17. Williamson J.D., Reith R.W., Jeffrey L.J., Arrand J.R., and Mackett M. Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. J Gen Virol 71 (1990) 2761-2767
18. Moore J.B., and Smith G.L. Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor. EMBO J 11 (1992) 1973-1980
19. Brandt T.A., and Jacobs B.L. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J Virol 75 (2001) 850-856
20. Sutter G., and Moss B. Nonreplicating vaccinia vector efficiently expressed recombinant genes. Proc Natl Acad Sci USA 89 (1992) 10847-10851
21. Guerra S., Lopez-Fernandez L.A., Conde R., Pascual-Montano A., Harshman K., and Esteban M. Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells. J Virol 78 (2004) 5820-5834
22. Phelps A., Gates A.J., Hillier M., Eastaugh L., and Ulaeto D.O. Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model. Vaccine 23 (2005) 3500-3507
23. Moss B. Poxviridae: the viruses and their replication. In: Knipe D.M., Howley P.M., Griffin D.E., Lamb R.A., Martin M., Roizman B., and Straus S.E. (Eds). Fields virology. 4th ed. vol. 2 (2001), Lippincott Williams & Wilkins, Philadelphia, PA 2849-2883
24. Li Z., Rubin S.A., Taffs R.E., Merchlinsky M., Ye Z., and Carbone K.M. Mouse neurotoxicity test for vaccinia-based smallpox vaccines. Vaccine 22 (2004) 1486-1493